Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis

Experimental Neurology
J B Leverenz, M A Raskind

Abstract

The presence of the neuropathological alterations of Alzheimer's disease (AD) in essentially all older Down syndrome (DS) patients suggests that the examination of younger DS patients may clarify the early pathological progression of AD. We examined the hippocampus and parahippocampal-inferior temporal gyri of 42 DS patients (ages 4 days to 38 years) for the deposition of amyloid beta protein (Abeta) using both a modified Bielschowsky stain and immunohistochemistry for Abeta protein. The parahippocampal and inferior temporal gyri demonstrated Abeta staining in cases as young as 8 years of age. As age and degree of Abeta deposition increased, staining included the CA-1/subiculum and dentate molecular layer followed then by the remainder of the CA hippocampal regions. The first neuritic plaques were observed in the CA-1/subiculum, despite this being a later region of Abeta deposition. Although Abeta staining increased with age, there was substantial variability in the severity of Abeta deposition within age groups. These results suggest that within the hippocampal/parahippocampal region there is a progressive stereotypic deposition of Abeta. The variable severity of Abeta deposition within age groups suggests that other factors, ...Continue Reading

Associated Clinical Trials

Dec 1, 2014·Dr. Alberto Costa

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jan 1, 1989·Acta Neuropathologica·H M WisniewskiK S Kim
May 1, 1988·Mechanisms of Ageing and Development·D M Mann
Mar 1, 1969·Brain : a Journal of Neurology·M I Olson, C M Shaw
Aug 1, 1948·The American Journal of Psychiatry·G A JERVIS

❮ Previous
Next ❯

Citations

Jun 15, 2011·Archives of Neurology·Linda D NelsonGary W Small
May 24, 2012·Acta Neuropathologica·Gerard D Schellenberg, Thomas J Montine
Jul 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Stephen D GinsbergElliott J Mufson
Jun 26, 2002·Journal of Clinical Pharmacy and Therapeutics·A F MaioriniR B Raffa
Apr 17, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Thomas D Bird
Mar 29, 2012·Current Gerontology and Geriatrics Research·Donna M Wilcock
Jul 20, 2013·Journal of Neuroinflammation·Donna M Wilcock, W Sue T Griffin
Aug 14, 2009·Alzheimer's Research & Therapy·Paul S Aisen
May 27, 2010·PloS One·Juliet A MoncasterLee E Goldstein
Nov 26, 2015·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Edmund C JenkinsWayne P Silverman
Jul 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Qian ShenRanjan Duara
Jan 26, 2010·Progress in Neurobiology·Andrea ContestabileLaura Gasparini
Oct 18, 2011·Journal of Neuropathology and Experimental Neurology·Heiko BraakKelly Del Tredici
Dec 16, 2010·Journal of Neuropathology and Experimental Neurology·Jerzy WegielCheng-Xin Gong
Nov 26, 2015·Biochimica Et Biophysica Acta·Donna M WilcockElizabeth Head
Nov 4, 2015·Frontiers in Behavioral Neuroscience·Xun Yu ChoongElizabeth M C Fisher
May 1, 2013·Wiley Interdisciplinary Reviews. Cognitive Science·Jamie O Edgin
Jan 27, 2005·Life Sciences·Santosh Sinha
Jan 11, 2005·Neurobiology of Aging·Ira T Lott, Elizabeth Head
Apr 21, 2006·Neurobiology of Aging·Marianna ZanaJános Kálmán
May 16, 2006·Biochemical and Biophysical Research Communications·Marianna ZanaJános Kálmán
Mar 27, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Lynn M BekrisJames B Leverenz
Aug 19, 2014·The Journal of Comparative Neurology·Melissa J AlldredStephen D Ginsberg
Aug 6, 2015·Nature Reviews. Neuroscience·Frances K WisemanAndré Strydom
Oct 20, 2011·Biochimica Et Biophysica Acta·Giovanna CeniniElizabeth Head
Apr 17, 2014·Biochimica Et Biophysica Acta·Marzia PerluigiFabio Di Domenico
Jul 23, 1999·Experimental Neurology·A Petronis
Sep 15, 2004·Der Pathologe·D R Thal, H Braak
Jun 26, 2017·Neurobiology of Disease·Susana García-CerroCarmen Martínez-Cué
Oct 31, 2002·Human Psychopharmacology·Kurt Heininger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.